China’s Allist Pharma raises $171m Series A led by Shiyu Capital

China’s Allist Pharma raises $171m Series A led by Shiyu Capital

Medical drugs in a pharmacy. Credit: Flickr/epSos .de

Chinese innovative drugs developer Allist Pharmaceuticals has raised RMB1.18 billion ($170.75 million) in a new funding round led by healthcare-focused private equity firm Shiyu Capital, according to an announcement.

Loyal Valley Capital and Suzhou Industrial Park Bioventure Investment also participated in the round.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter